Similarly, 2 treated mice (including one mouse without ZsGreen expression) exhibited 5,393±3,955 Wt1 copies/104Abl1 (53.9%Wt1/Abl1) (~2-fold better than in AML-succumbing mice, with a mean of 2,323±807.8 Wt1 copies/104Abl1 in 66% mice) (Fig 5C). The gene discussed is ABL1; the disease is acute myeloid leukemia.